Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists

被引:5
|
作者
Zhou, Ya-Ju
Zhu, Li-Ping
Tang, Yun
Ye, De-Yong
机构
[1] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
[2] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 200032, Peoples R China
关键词
structure-based; 3D-QSAR; CoMFA; CoMSIA; 5-HT3; receptor;
D O I
10.1016/j.ejmech.2006.12.029
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-based 3D-QSAR studies were perfortned on a series of novel heteroarylpiperazine derivatives as 5-HT3 receptor antagonists with comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methods. The compounds were initially docked into the binding pocket of the homology model of 5-HT3 receptor using GOLD program. The docked conformations with the highest score were then extracted and used to build the 3D-QSAR models, with cross-validated 1-2 values 0.716 and 0.762 for CoMFA and CV CoMSIA, respectively. The CoMFA and CoMSIA contour plots were also fitted into the 3D structural model of the receptor to identify the key interactions between them, which might be helpful for designing new potent 5-HT3 receptor antagonists. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:977 / 984
页数:8
相关论文
共 50 条
  • [31] Structural features of GABAA receptor antagonists: pharmacophore modeling and 3D-QSAR studies
    Wei Zhang
    Shuang Xia
    Jinjin Ye
    Yun Tang
    Zhong Li
    Weiping Zhu
    Jiagao Cheng
    Medicinal Chemistry Research, 2013, 22 : 5961 - 5972
  • [32] New benzimidazole derivatives:: selective and orally active 5-HT3 receptor antagonists
    Pascual, D
    Girón, R
    Alsasua, A
    Benhamú, B
    López-Rodríiguez, ML
    Martín, MI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 462 (1-3) : 99 - 107
  • [33] Additional binding mechanism of palonosetron to the 5-HT3 receptor versus first generation 5-HT3 receptor antagonists
    Rojas, C.
    Stathis, M.
    Alt, J.
    Rubenstein, E.
    Cantoreggi, S.
    Sebastiani, S.
    Slusher, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Structural features of GABAA receptor antagonists: pharmacophore modeling and 3D-QSAR studies
    Zhang, Wei
    Xia, Shuang
    Ye, Jinjin
    Tang, Yun
    Li, Zhong
    Zhu, Weiping
    Cheng, Jiagao
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (12) : 5961 - 5972
  • [35] Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists
    Lasheras, B
    Berjon, A
    Montanes, R
    Roca, J
    Romero, G
    Ramirez, MJ
    DelRio, J
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1996, 46 (04): : 401 - 406
  • [36] MECHANISM OF THE ANTIEMETIC ACTIVITY OF 5-HT3 RECEPTOR ANTAGONISTS
    TYERS, MB
    FREEMAN, AJ
    ONCOLOGY, 1992, 49 (04) : 263 - 268
  • [37] 5-HT3 ANTAGONISTS AND EMESIS
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1990, 44 (04): : 293 - 293
  • [38] 5-HT3 RECEPTOR ANTAGONISTS - A NEW CLASS OF ANTIEMETICS
    不详
    LANCET, 1987, 1 (8548): : 1470 - 1471
  • [39] EMERGING DIFFERENCES BETWEEN 5-HT3 RECEPTOR ANTAGONISTS
    MARR, HE
    DAVEY, PT
    BARTLETT, AJ
    ANTI-CANCER DRUGS, 1991, 2 (06) : 513 - 518
  • [40] Current experience with 5-HT3 receptor antagonists in fibromyalgia
    Späth, M
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2002, 28 (02) : 319 - +